Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) Short Interest Update

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totaling 2,710 shares, a decrease of 52.3% from the April 30th total of 5,686 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 2,016 shares, the days-to-cover ratio is currently 1.3 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of Aimei Health Technology in a report on Friday, March 27th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

Aimei Health Technology Price Performance

NASDAQ:AFJK traded up $0.09 during trading hours on Monday, reaching $42.09. 633 shares of the company traded hands, compared to its average volume of 21,302. The firm’s 50-day moving average is $38.78 and its 200-day moving average is $38.66. The stock has a market cap of $133.42 million, a P/E ratio of 233.83 and a beta of 0.23. Aimei Health Technology has a 1-year low of $6.75 and a 1-year high of $130.37.

Aimei Health Technology (NASDAQ:AFJK) last issued its quarterly earnings results on Monday, May 4th. The company reported $0.02 earnings per share for the quarter.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Jane Street Group LLC purchased a new stake in Aimei Health Technology during the fourth quarter valued at about $302,000. Dakota Wealth Management purchased a new stake in Aimei Health Technology during the fourth quarter valued at about $406,000. Geode Capital Management LLC purchased a new stake in Aimei Health Technology during the fourth quarter valued at about $413,000. Quarry LP grew its position in Aimei Health Technology by 6.4% during the third quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after acquiring an additional 10,000 shares during the period. Finally, Clear Street Group Inc. grew its position in Aimei Health Technology by 36.5% during the fourth quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock valued at $5,334,000 after acquiring an additional 22,294 shares during the period. Hedge funds and other institutional investors own 45.58% of the company’s stock.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.